At the 20th Annual Hirshberg Symposium, Dr. Margaret Tempero, the Director of the Cancer Early Detection and Interception Initiative and the leader of the Pancreas Center Program at the UCSF […]
New Vaccine to Prevent Pancreatic Cancer in High-Risk Patients
Using an “off-the-shelf” vaccine, researchers from Johns Hopkins Kimmel School of Medicine and Skip Viragh Center for Pancreatic Cancer have demonstrated, for the first time, the ability to generate an […]
Targeting RAS in Pancreatic Cancer: A New Reality
RAS Inhibition: A New Era for Pancreatic Cancer Treatment The RAS family of proteins have long been an area of study for understanding and targeting in pancreatic cancer. The exciting […]
Hope on the Horizon, a 2026 Progress Report on Pancreatic Cancer
At the 20th Annual Symposium on Pancreatic Cancer, Dr. Timothy Donahue, Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases, presented the Pancreatic Cancer Progress Report for 2026. Dr. […]
Early-stage clinical trials show promising results in pancreatic cancer
Between May 29th and June 2nd, 2026, clinicians and researchers from around the world gathered in Chicago, IL for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The […]
Updated NCCN Guidelines for Patients Reflect the Latest Advances in Pancreatic Cancer Care
The latest edition of the NCCN Guidelines for Patients: Pancreatic Cancer is now available, providing patients and caregivers with updated information to help them better understand treatment options, ask informed […]